TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 88,700 shares, a decrease of 56.8% from the November 30th total of 205,400 shares. Based on an average trading volume of 22,700 shares, the days-to-cover ratio is presently 3.9 days. […]
TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) was the target of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 88,700 shares, a drop of 56.8% from the November 30th total of 205,400 shares. Currently, 0.9% of the company’s stock are short sold. Based […]
StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Saturday. The firm issued a hold rating on the stock. Separately, Cantor Fitzgerald reaffirmed a neutral rating on shares of TherapeuticsMD in a report on Thursday, August 17th. View Our Latest Stock Report on TXMD TherapeuticsMD Price Performance […]
StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the stock. Separately, Cantor Fitzgerald reissued a neutral rating on shares of TherapeuticsMD in a research note on Thursday, August 17th. View Our Latest Report on TXMD […]
StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the stock. Separately, Cantor Fitzgerald reissued a neutral rating on shares of TherapeuticsMD in a report on Thursday, August 17th. View Our Latest Stock Report on TXMD TherapeuticsMD Stock Down […]